Apollo Silver Corp
OTC:APGOF
Apollo Silver Corp
OTC:APGOF
Price:
2.4
USD
4.35%
Market Cap:
$419.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apollo Silver Corp
OTC:APGOF
|
CA |
|
E
|
Elicera Therapeutics AB
STO:ELIC
|
SE |
|
Olive Tree Estates Ltd
SGX:1H2
|
SG |
|
N
|
Netskope Inc
NASDAQ:NTSK
|
US |
|
O
|
Ovation Science Inc
CNSX:OVAT
|
CA |
Balance Sheet
Balance Sheet Decomposition
Apollo Silver Corp
Apollo Silver Corp
Balance Sheet Decomposition is not available for
Apollo Silver Corp
Apollo Silver Corp
Balance Sheet
Apollo Silver Corp
Apollo Silver Corp
Currency: CAD
| Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | Nov-2024 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
6
|
16
|
18
|
3
|
14
|
32
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
6
|
16
|
9
|
3
|
13
|
31
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
6
|
17
|
10
|
4
|
14
|
34
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
78
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
0
N/A
|
0
+64%
|
0
-67%
|
0
+240%
|
0
-69%
|
6
+25 704%
|
95
+1 400%
|
10
-89%
|
4
-61%
|
14
+261%
|
34
+141%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-24%
|
0
+21%
|
0
+20%
|
0
+58%
|
0
-33%
|
3
+1 743%
|
2
-9%
|
0
-85%
|
0
+11%
|
1
+90%
|
|
| Equity | ||||||||||||
| Common Stock |
6
|
6
|
6
|
6
|
6
|
13
|
99
|
102
|
102
|
115
|
141
|
|
| Retained Earnings |
6
|
6
|
6
|
6
|
6
|
7
|
8
|
94
|
98
|
101
|
108
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
+71%
|
0
-286%
|
0
+36%
|
0
-229%
|
6
N/A
|
92
+1 392%
|
8
-92%
|
4
-53%
|
14
+287%
|
33
+142%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+64%
|
0
-67%
|
0
+240%
|
0
-69%
|
6
+25 704%
|
95
+1 400%
|
10
-89%
|
4
-61%
|
14
+261%
|
34
+141%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
3
|
1
|
3
|
4
|
4
|
10
|
33
|
35
|
35
|
48
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
